Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,276 | 120 | 86.4% |
| Education | $984.22 | 13 | 13.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,310 | 20 | $0 (2024) |
| Astellas Pharma US Inc | $1,088 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $873.70 | 14 | $0 (2021) |
| ABBVIE INC. | $560.45 | 23 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $444.14 | 4 | $0 (2020) |
| Amarin Pharma Inc. | $399.65 | 9 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $375.00 | 3 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $323.34 | 8 | $0 (2021) |
| PFIZER INC. | $281.90 | 12 | $0 (2023) |
| Abbott Laboratories | $275.00 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $826.37 | 11 | Amgen Inc. ($331.85) |
| 2023 | $1,079 | 16 | Amgen Inc. ($487.79) |
| 2022 | $822.68 | 18 | Amgen Inc. ($168.15) |
| 2021 | $1,109 | 30 | Astellas Pharma US Inc ($381.25) |
| 2020 | $761.39 | 23 | AstraZeneca Pharmaceuticals LP ($147.40) |
| 2019 | $1,222 | 14 | AstraZeneca Pharmaceuticals LP ($373.89) |
| 2018 | $721.66 | 11 | Merck Sharp & Dohme Corporation ($218.92) |
| 2017 | $718.26 | 10 | AstraZeneca Pharmaceuticals LP ($297.87) |
All Payment Transactions
133 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Diabetes Care | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $34.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes Care | ||||||
| 07/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: Inflammation | ||||||
| 07/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 03/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Inflammation | ||||||
| 02/07/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $79.99 | General |
| 02/01/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Inflammation | ||||||
| 01/10/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $90.00 | General |
| 12/05/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Biological | ||||||
| 11/29/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | CYCLOSET (Drug) | Food and Beverage | In-kind items and services | $124.94 | General |
| Category: Neurology | ||||||
| 11/07/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: Inflammation | ||||||
| 10/30/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 09/18/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Inflammation | ||||||
| 09/05/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: Inflammation | ||||||
| 08/22/2023 | Intuity Medical Inc | Pogo Automatic Blood Glucose Monitoring System (Device) | Food and Beverage | Cash or cash equivalent | $123.11 | General |
| Category: Diabetes | ||||||
| 06/13/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Biological | ||||||
| 06/06/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: Biological | ||||||
| 05/30/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $57.40 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/23/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: Inflammation | ||||||
| 03/28/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: UROLOGY | ||||||
| 03/15/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $94.00 | General |
| 03/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,514 | 4,684 | $417,858 | $254,452 |
| 2022 | 16 | 1,784 | 5,306 | $465,437 | $282,714 |
| 2021 | 19 | 2,041 | 6,178 | $481,686 | $304,011 |
| 2020 | 17 | 2,284 | 7,136 | $564,735 | $367,732 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 254 | 1,754 | $157,878 | $104,801 | 66.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 237 | 1,019 | $130,578 | $92,231 | 70.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 120 | 120 | $42,000 | $18,126 | 43.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 58 | 139 | $13,900 | $7,805 | 56.2% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 85 | 86 | $12,059 | $6,814 | 56.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 57 | 126 | $9,425 | $5,405 | 57.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 133 | 393 | $12,891 | $5,054 | 39.2% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 43 | 87 | $7,201 | $3,063 | 42.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 169 | 313 | $12,520 | $2,629 | 21.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 69 | 69 | $5,175 | $2,311 | 44.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $3,934 | $2,188 | 55.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 65 | 65 | $1,849 | $1,812 | 98.0% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 13 | 13 | $1,924 | $1,062 | 55.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 49 | 52 | $1,674 | $656.72 | 39.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 130 | 404 | $4,570 | $481.24 | 10.5% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 16 | 28 | $280.00 | $12.18 | 4.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 262 | 1,131 | $142,967 | $102,284 | 71.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 271 | 1,718 | $151,121 | $102,009 | 67.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 161 | 161 | $56,350 | $25,247 | 44.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 107 | 304 | $30,350 | $18,107 | 59.7% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 107 | 108 | $15,133 | $8,709 | 57.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 68 | 161 | $12,050 | $7,339 | 60.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 148 | 481 | $14,999 | $6,395 | 42.6% |
| 96374 | Injection of drug or substance into vein | Office | 2022 | 86 | 143 | $10,714 | $5,036 | 47.0% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 66 | 67 | $5,360 | $2,005 | 37.4% |
About Dr. Ebrahim Sadighim, MD
Dr. Ebrahim Sadighim, MD is a Internal Medicine healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215021530.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ebrahim Sadighim, MD has received a total of $7,260 in payments from pharmaceutical and medical device companies, with $826.37 received in 2024. These payments were reported across 133 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($6,276).
As a Medicare-enrolled provider, Sadighim has provided services to 7,623 Medicare beneficiaries, totaling 23,304 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Great Neck, NY
- Active Since 10/03/2006
- Last Updated 04/16/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1215021530
Products in Payments
- Otezla (Drug) $690.13
- Repatha (Biological) $619.49
- FARXIGA (Drug) $544.01
- SPRAVATO (Drug) $444.14
- Vascepa (Drug) $399.65
- JARDIANCE (Drug) $375.00
- FREESTYLE LIBRE 3 (Device) $275.00
- FASENRA (Drug) $262.25
- Pogo Automatic Blood Glucose Monitoring System (Device) $237.89
- CREON (Drug) $220.57
- JANUVIA (Drug) $175.60
- LINZESS (Drug) $171.58
- Creon (Drug) $168.30
- Roszet (Drug) $153.00
- Tymlos (Biological) $125.00
- CYCLOSET (Drug) $124.94
- NATPARA (PARATHYROID HORMONE) (Drug) $124.94
- PRALUENT ALIROCUMAB INJECTION (Biological) $120.29
- ZENPEP (Drug) $116.05
- Strensiq (Drug) $112.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Great Neck
Dr. Jamie Hirsch, Md, MD
Internal Medicine — Payments: $69,165
Joanne Lee, M.d, M.D
Internal Medicine — Payments: $36,469
Bernard Rosof
Internal Medicine — Payments: $26,679
Dr. Shahram Shamekh, Md, MD
Internal Medicine — Payments: $18,187
Sanford Ratner, M.d, M.D
Internal Medicine — Payments: $16,933
David Edelson, Md, MD
Internal Medicine — Payments: $15,163